Pretransplant serum human chitinase-like glycoprotein YKL-40 concentrations independently predict bronchiolitis obliterans development in lung transplant recipients

Journal of Thoracic and Cardiovascular Surgery

Volumn 148, Issue 1, 2014, Pages 273-281

  Jaksch, Peter ^a   Taghavi, Shahrokh ^a   Klepetko, Walter ^a   Salama, Mohamed ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b OTTO WAGNER HOSPITAL   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; GLYCOPROTEIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISOLONE; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG; YKL 40 PROTEIN;

ADULT; ARTICLE; BLOOD SAMPLING; BRONCHIOLITIS OBLITERANS; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG PULSE THERAPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT RECIPIENT; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG GRAFT REJECTION; LUNG LAVAGE; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PNEUMOCYSTIS PNEUMONIA; PREDICTION; PRIMARY GRAFT DYSFUNCTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TOXOPLASMOSIS;

ADIPOKINES; ADULT; AGED; BIOLOGICAL MARKERS; BRONCHIOLITIS OBLITERANS; BRONCHOALVEOLAR LAVAGE FLUID; CHI-SQUARE DISTRIBUTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LECTINS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; UP-REGULATION;

EID: 84902544368     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2014.02.059     Document Type: Article

References (26)

1. M. Estenne, J.R. Maurer, A. Boehler, J.J. Egan, A. Frost, and M. Hertz et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria J Heart Lung Transplant 21 2002 297 310
2. C.A. Finlen Copeland, L.D. Snyder, D.W. Zaas, W.J. Turbyfill, W.A. Davis, and S.M. Palmer Survival after bronchiolitis obliterans syndrome among bilateral lung transplant recipients Am J Respir Crit Care Med 182 2010 784 789
3. A.I. Scott, L.D. Sharples, and S. Stewart Bronchiolitis obliterans syndrome: risk factors and therapeutic strategies Drugs 65 2005 761 771
4. S.S. Weigt, W.D. Wallace, A. Derhovanessian, R. Saggar, R. Saggar, and J.P. Lynch et al. Chronic allograft rejection: epidemiology, diagnosis, pathogenesis, and treatment Semin Respir Crit Care Med 31 2010 189 207
5. J.L. Todd, and S.M. Palmer Bronchiolitis obliterans syndrome: the final frontier for lung transplantation Chest 140 2011 502 508
6. C.M. Burton, M. Iversen, J. Carlsen, J. Mortensen, C.B. Andersen, and D. Steinbrüchel et al. Acute cellular rejection is a risk factor for bronchiolitis obliterans syndrome independent of post-transplant baseline FEV1 J Heart Lung Transplant 28 2009 888 893
7. F. Meloni, N. Solari, S. Miserere, M. Morosini, A. Cascina, and C. Klersy et al. Chemokine redundancy in BOS pathogenesis. A possible role also for the CC chemokines: MIP3-beta, MIP3-alpha, MDC and their specific receptors Transpl Immunol 18 2008 275 280
8. M. Salama, P. Jaksch, O. Andrukhova, S. Taghavi, W. Klepetko, and S. Aharinejad Endothelin-1 is a useful biomarker for early detection of bronchiolitis obliterans in lung transplant recipients J Thorac Cardiovasc Surg 140 2010 1422 1427
9. J.A. Park, J.M. Drazen, and D.J. Tschumperlin The chitinase-like protein YKL-40 is secreted by airway epithelial cells at base line and in response to compressive mechanical stress J Biol Chem 285 2010 29817 29825
10. S. Létuvé, A. Kozhich, N. Arouche, M. Grandsaigne, J. Reed, and M.C. Dombret et al. YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages J Immunol 181 2008 5167 5173
11. N.M. Korthagen, C.H. van Moorsel, N.P. Barlo, H.J. Ruven, A. Kruit, and M. Heron et al. Serum and BALF YKL-40 levels are predictors of survival in idiopathic pulmonary fibrosis Respir Med 105 2011 106 113
12. G.L. Chupp, C.G. Lee, N. Jarjour, Y.M. Shim, C.T. Holm, and S. He et al. A chitinase-like protein in the lung and circulation of patients with severe asthma N Engl J Med 357 2007 2016 2027
13. C.G. Lee, D. Hartl, G.R. Lee, B. Koller, H. Matsuura, and C.A. Da Silva et al. Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis J Exp Med 206 2009 1149 1166
14. M. Salama, O. Andrukhova, P. Jaksch, S. Taghavi, W. Kelpetko, and G. Dekan et al. Endothelin-1 governs proliferation and migration of bronchoalveolar lavage-derived lung mesenchymal stem cells in bronchiolitis obliterans syndrome Transplantation 92 2011 155 162
15. S. Aharinejad, S. Taghavi, W. Klepetko, and D. Abraham Prediction of lung-transplant rejection by hepatocyte growth factor Lancet 363 2004 1503 1508
16. B.M. Vanaudenaerde, S.I. De Vleeschauwer, R. Vos, I. Meyts, D.M. Bullens, and V. Reynders et al. The role of the IL23/IL17 axis in bronchiolitis obliterans syndrome after lung transplantation Am J Transplant 8 2008 1911 1920
17. S. Taghavi, K. Krenn, P. Jaksch, W. Klepetko, and S. Aharinejad Broncho-alveolar lavage matrix metalloproteases as a sensitive measure of bronchiolitis obliterans Am J Transplant 5 2005 1548 1552
18. H. Matsuura, D. Hartl, M.J. Kang, C.S. Dela Cruz, B. Koller, and G.L. Chupp et al. Role of breast regression protein-39 in the pathogenesis of cigarette smoke-induced inflammation and emphysema Am J Respir Cell Mol Biol 44 2011 777 786
19. Z. Zhu, T. Zheng, R.J. Homer, Y.K. Kim, N.Y. Chen, and L. Cohn et al. Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation Science 304 2004 1678 1682
20. S. Létuvé, A. Kozhich, A. Humbles, Y. Brewah, M.C. Dombret, and M. Grandsaigne et al. Lung chitinolytic activity and chitotriosidase are elevated in chronic obstructive pulmonary disease and contribute to lung inflammation J Immunol 173 2004 4020 4049
21. A. Borowski, M. Kuepper, U. Horn, U. Knüpfer, G. Zissel, and K. Höhne et al. Interleukin-13 acts as an apoptotic effector on lung epithelial cells and induces pro-fibrotic gene expression in lung fibroblasts Clin Exp Allergy 38 2008 619 628
22. M. Kaviratne, M. Hesse, M. Leusink, A.W. Cheever, S.J. Davies, and J.H. McKerrow et al. IL-13 activates a mechanism of tissue fibrosis that is completely TGF-beta independent J Immunol 173 2004 4020 4029
23. M.P. Keane, B.N. Gomperts, S. Weigt, Y.Y. Xue, M.D. Burdick, and H. Nakamura et al. IL-13 is pivotal in the fibro-obliterative process of bronchiolitis obliterans syndrome J Immunol 178 2007 511 519
24. W. Jungraithmayr, L. Ji, L. Yang, W. Weder, S. Korom, and M. Hersberger Increased T-bet to GATA-3 ratio during acute allograft rejection in the rat lung Transplant Proc 41 2009 4316 4320
25. E.A. Kastelijn, G.T. Rijkers, C.H. Van Moorsel, P. Zanen, J.M. Kwakkel-van Erp, and E.A. Van De Graaf et al. Systemic and exhaled cytokine and chemokine profiles are associated with the development of bronchiolitis obliterans syndrome J Heart Lung Transplant 29 2010 997 1008
26. E. Mamessier, A.M. Lorec, P. Thomas, M. Badier, A. Magnan, and M. Reynaud-Gaubert T regulatory cells in stable posttransplant bronchiolitis obliterans syndrome Transplantation 84 2007 908 916